---
schema_version: "secwatch.filing_event.v1"
accession: "0000950170-25-038316"
form_type: "8-K"
ticker: "AVAH"
cik: "0001832332"
company_name: "Aveanna Healthcare Holdings, Inc."
filed_at: "2025-03-13T23:59:59+00:00"
generated_at: "2026-05-24T21:33:42.849405+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# Aveanna Q4 2024 revenue $519.9M (+8.6%), net income $29.2M vs loss; Adj. EBITDA +42.8%; FY2025 guidance

## Summary
- Q4 revenue $519.9M (+8.6% YoY); gross margin $171.7M (33.0%) up 15.7%.
- Q4 net income $29.2M vs net loss $25.7M; diluted EPS $0.14 vs ($0.13).
- Q4 adjusted net income $11.1M (+$14.3M); adjusted diluted EPS $0.05 vs ($0.02).
- Q4 Adjusted EBITDA $55.2M (+42.8%); FY2024 revenue >$2B, Adj. EBITDA >$183M.
- FY2025 guidance: revenue $2.10–$2.12B; Adj. EBITDA $190–$194M.

## SEC filing metadata
- accession: 0000950170-25-038316
- form_type: 8-K
- ticker: AVAH
- cik: 0001832332
- company_name: Aveanna Healthcare Holdings, Inc.
- filed_at: 2025-03-13T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 2.02, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1832332/000095017025038316/0000950170-25-038316-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1832332/000095017025038316/avah-20250313.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000950170-25-038316
- JSON: https://secwatch.observer/filing/0000950170-25-038316.json
- Plain text: https://secwatch.observer/filing/0000950170-25-038316.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.